IL-10 expression is regulated by HPV E2 protein in cervical cancer cells

Molecular Medicine Reports

Volumn 4, Issue 2, 2011, Pages 369-375

  Bermudez Morales V H ^a   Peralta Zaragoza, O ^a   Alcocer Gonzalez J M ^b   Moreno, J ^a   Madrid Marina, Vicente ^a  

^a National Institute of Public Heath   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

Author keywords

Cervical cancer; E2; Human papillomavirus 16; Interleukin 10

Indexed keywords

INTERLEUKIN 10; MESSENGER RNA; PAPILLOMAVIRUS E2 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CANCER CELL; CELL ACTIVITY; CELL CULTURE; CELL LINE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; PAPILLOMAVIRUS INFECTION; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; UTERINE CERVIX CANCER;

BASE SEQUENCE; CELL LINE, TUMOR; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-10; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; PROMOTER REGIONS, GENETIC; TRANSCRIPTIONAL ACTIVATION; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS - 16; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 79551704609     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.429     Document Type: Article

References (38)

1. zur Hausen H: Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342-350, 2002.
2. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Munoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19, 1999. (Pubitemid 29406813)
3. Clerici M, Merola M, Ferrario E, Trwabattoni D, Villa ML, Stefanon B, Venzon DJ, Shearer GM, de Palo G and Clerici E: Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J Natl Cancer Inst 89: 185-187, 1987.
4. Bais AG, Beckmann I, Lindemans J, Ewing PC, Meijer CJ, Snijders PJ and Heimerhorst TJ: a shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions. J clin Pathol 58: 1096-100, 2005. (Pubitemid 41416062)
5. El-Sherif AM, Seth R, Tighe PJ and Jenkins D: Quantitative analysis of IL-10 and IFN-gamma mRNA levels in normal cervix and human papillomavirus type 16 associated cervical precancer. J Pathol 195: 179-185, 2001. (Pubitemid 32899026)
6. Bermúdez-Morales VH, Burguete AI, Gutierrez ML, Alcocer-González JM and Madrid-Marina V: correlation between IL-10 expression and human papillomavirus infection in cervical cancer, a mechanism for immune response escape. Cancer Invest 26: 1037-1043, 2008.
7. De Waal Malefyt R, Haanen J, Roncarolo MG, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H and de Vries JE: Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 74: 915-924, 1991.
8. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG and de Vries JE: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174: 1209-1220, 1991.
9. Díaz-Benítez CE, Navarro-Fuentes KR, Flores-Sosa Ja, et al: CD3zeta expression and T cell proliferation are inhibited by TGF-beta1 and IL-10 in cervical cancer patients. J Clin Immunol 29: 532-544, 2009.
10. Bhairavabhotla RK, Verm V, Tongaonkar H, Shastri S, Dinshaw K and Chiplunkar S: Role of IL-10 in immune suppression in cervical cancer. Indian J Biochem Biophys 44: 350-356, 2007. (Pubitemid 351481352)
11. Desaintes C, Hallez S, van Alphen P and Burny A: Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16. J Virol 66: 325-333, 1992.
12. Desaintes C and Demeret C: control of papillomavirus DNA replication and transcription. Semin Cancer Biol 7: 339-347, 1996. (Pubitemid 27380013)
13. Hoffmann R, Hirt B, Bechtold V, Beard P and Raj K: Different modes of human papillomavirus DNA replication during maintenance. J Virol 80: 4431-4439, 2006.
14. Genther SM, Sterling S, Duensing S, Münger K, Sattler C and Lambert PF: Quantitative role of the human papillomavirus type 16 E5 gene during the productive stage of the viral life cycle. J Virol 77: 2832-2842, 2003. (Pubitemid 36228066)
15. Hartley KA and Alexander KA: Human TATA binding protein inhibits human papillomavirus type 11 DNA replication by antagonizing E1-E2 protein complex formation on the viral origin of replication. J Virol 76: 5014-5023, 2002. (Pubitemid 34441706)
16. Dey A, Atcha IA and Bagchi S: HPV16 E6 oncoprotein stimulates the transforming growth factor-beta 1 promoter in fibroblasts through a specific GC-rich sequence. Virology 228: 190-199, 1997. (Pubitemid 27238785)
17. Peralta-Zaragoza O, Bermúdez-Morales VH, Gutiérrez- Xicotencatl L, Alcocer-González JM, Recillas-Targa F and Madrid-Marina V: E6 and E7 oncoprotein from human papillomavirus type 16 induce activation of human transforming growth factor beta-1 promoter throughout Sp1 regulatory element. Viral Immunol 19: 468-480, 2006.
18. Kube D, Platzer C, von Knethen A, Straub H, Bohlen H, Hafner M and Tesch H: Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines. Cytokine 7: 1-7, 1995.
19. Eskdale J, Kube D, Tesch H and Gallager G: Mapping of the human IL-10 gene and further characterisation of the 5′-flanking sequence. Immunogenetics 46: 120-128, 1997. (Pubitemid 27234709)
20. Kube D, Rieth H, Eskdale J, Kremsner PG and Gallagher G: Structural characterization of the distal 5′ flanking region of the human interleukin-10 gene. Genes Immun 2: 181-190, 2001. (Pubitemid 33676981)
21. Androphy EJ, Lowy DR and Schiller JL: Bovine papillomavirus E2 transactivating gene product binds to specifIc sites in papillomavirus DNA. Nature 325: 70-73, 1987. (Pubitemid 17059472)
22. Guido M, Zamorano R, Garrido-Guerrero E, Gariglio P and García-Carrancá A: early promoters of genital and cutaneous human papillomaviruses are differentially regulated by the bovine papillomavirus type 1 E2 gene product. J Gen Virol 73: 1395-1400, 1992.
23. Stenlund A and Botchan MR: The E2 trans-activator can act as a repressor by interfering with a cellular transcription factor. Genes Dev 4: 123-136, 1990.
24. Veress G, Szarka K, Dong XP, Gergely L and PfIster H: Functional signifIcance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16. J Gen Virol 80: 1035-1043, 1999. (Pubitemid 29179065)
25. Sambrook J, Fritsch EF and Maniatis L: Molecular Cloning Laboratory Manual. 2nd edition. Cold Spring Harbor laboratory Press, pp89-99, 1989.
26. Alcocer-González JM, Berumen Jaime, Laméz-Guerra R, Bermúdez-Morales V, Peralta-Zaragoza O, Hernández-Pando R, Moreno J, Gariglio P and Madrid-Marina V: In vivo expression of immunosuppressive cytokines in human papillomavirus-transformed cervical cancer cells. Viral Immunol 19: 481-491, 2006.
27. Filippi CM and von Herrath MG: IL-10 and the resolution of infections. J Pathol 214: 224-230, 2008.
28. Moore WK, Malefyt WR, Coffman LR and O'Garra A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19: 683-765, 2001.
29. Azar KK, Tani M, Yasuda H, Sakai A, Inoue M and Sasagawa T: Increased secretion patterns of interleukin-10 and tumor necrosis factor-alpha in cervical squamous intraepithelial lesions. Hum Pathol 35: 1376-1384, 2004. (Pubitemid 39601578)
30. Bhairavabhotla RK, Verm V, Tongaonkar H, Shastri S, Dinshaw K and Chiplunkar S: role of IL-10 in immune suppression in cervical cancer. Indian J Biochem Biophys 44: 350-356, 2007. (Pubitemid 351481352)
31. Burdin N, Péromie C, Banchereau J and Rousset F: Epstein-Barr virus Induces B lymphocytes to produce human interleukin-10. J Exp Med 177: 295-305, 1993.
32. Akridge RE, Oyafuso LKM and Reed SG: IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J Immunol 153: 5782, 1994.
33. Arany A, Grattendick KG and Tyring SK: Interleukin-10 induces transcription of the early promoter of human papillomavirus type 16 (HPV16) through the 5′-segment of the upstream regulatory region (URR). Antiviral Res 55: 331-339, 2002.
34. Shino Y, Shirasawa H, Kinoshita T and Simizu B: Human papillomavirus type 16 E6 protein transcriptionally modulates fibronectin gene expression by induction of protein complex binding to the cyclic AMP response element. J Virol 71: 4310-4318, 1997. (Pubitemid 27204118)
35. Kinoshita T, Shirasawa H, Shino Y, Moriya H, Desbarats L, Eilers M and Simizu B: Transactivation of prothymosin alpha and c-myc promoters by human papillomavirus type 16 E6 protein. Virology 232: 53-61, 1997. (Pubitemid 27244462)
36. Phillips AC and Vousden KH: analysis if the interaction between human papillomavirus type 16 E7 and TATA-binding protein, TBP. J Gen Virol 78: 905-909, 1997. (Pubitemid 27179757)
37. Chen SL, Lin YK, Li LY, Tsao YP, Lo HY, Wang WB and Tsai TC: E5 proteins of human papillomavirus types 11 and 16 transactivate the c-fos promoter through the NF1 binding element. J Virol 70: 8558-8563, 1996.
38. DeVoti JA, Steinberg BM, Rosenthal DW, Hatam L, Vambutas A, Abramson AL, Shikowitz MJ and Bonagura VR: Failure of gamma interferon but not interleukin-10 expression in response to human papillomavirus type 11 E6 protein in respiratory papillomatosis. Clin Diagn Lab Immunol 83: 538-547, 2004. (Pubitemid 38661420)